EDINET DISCLOSURE · 全国企業データベース

バークレイズ・ピーエルシー|外国会社臨時報告書|EDINET開示書類

提出企業
バークレイズ・ピーエルシー
書類名
外国会社臨時報告書
提出日時
2026-10-19 16:32:00
EDINET書類ID
S100Z8UK

本ページはEDINETの開示書類から抽出したHTMLです。画像・図表・脚注や複雑な表組みは原本と一致しない場合があります。重要な判断にはEDINET公式の原本を確認してください。

開示書類本文

【表紙】

 

【提出書類】

外国会社臨時報告書

【提出先】

関東財務局長

【提出日】

令和8年10月19日

【会社名】

 

バークレイズ・ピーエルシー

(Barclays PLC)

【代表者の役職氏名】

グループ財務担当取締役

(Group Finance Director)

アンナ・クロス

(Anna Cross)

【本店の所在の場所】

 

英国 ロンドン市 E14 5HP チャーチル・プレイス 1

(1 Churchill Place, London E14 5HP, United Kingdom)

【代理人の氏名又は名称】

弁護士  芦 澤 千 尋

【代理人の住所又は所在地】

東京都港区虎ノ門4丁目3番1号 城山トラストタワー30階

アシャースト・パーキンズ・クイ法律事務所・外国法共同事業

【電話番号】

03-5405-6200

【事務連絡者氏名】

弁護士  芦 澤 千 尋

【連絡場所】

 

東京都港区虎ノ門4丁目3番1号 城山トラストタワー30階

アシャースト・パーキンズ・クイ法律事務所・外国法共同事業

【電話番号】

03-5405-6200

【縦覧に供する場所】

該当事項なし

 

1【提出理由】

バークレイズ・ピーエルシー(以下「Barclays」、「the Company」又は「バークレイズ」といいます。)は、バークレイズ・グループSAYEシェア・オプション制度(以下「Sharesave」といいます。)に従い、株式貯蓄制度の条件に基づいて英国、ジャージー、ガーンジー及びマン島におけるバークレイズ・グループの従業員を対象として、新株予約権(Option)の募集を開始しました。

よって、金融商品取引法第24条の5第4項及び第15項並びに企業内容等の開示に関する内閣府令第19条第1項及び第2項第1号の規定に基づき、以下のとおり本外国会社臨時報告書を提出いたします。

(注)本書に記載の「£」は、別段の記載がある場合を除き、英国のスターリング・ポンド(以下「英ポンド」といいます。)を指すものとする。本書において日本円への換算は、1ポンド=208.11円の為替レート(2026年9月30日現在の株式会社三菱UFJ銀行による電信直物相場の対顧客売買仲値)によりなされている。但し、英ポンド建ての金額がかかる為替レートにおいて日本円に換算されていたこと、換算することができたはずであったこと、又は換算できることを表明するものではない。

 

2【報告内容】

 

(1)      Type and Name of Securities to be Issued:

 

Share acquisition rights (the "Options")

 

(2)      Number of Securities to be Issued:

 

          20,506,833 (estimated amount)

 

Note:

Total of an estimated amounts of the Options could be granted to Eligible Sharesave Employees (as defined below) in the United Kingdom, Jersey, Guernsey and the Isle of Man (20,506,833).

 

(3)      Issue Price and Amount to be incorporated to Capital:

 

(i)                 Issue price: £0 (JPY0)

 

(ii)               Amount to be incorporated into capital: £0 (JPY0)

 

Note:

Options shall be granted to those eligible employees outside Japan without involving any payment.

 

(4)      Aggregate Total Issue Price and Total Amount to be Incorporated to Capital:

 

(i)                 Aggregate total amount to be issued: £0 (JPY0)

 

(ii)              Aggregate amount to be incorporated into capital: £0 (JPY0)

 

Note:

An estimated total exercise price of Options to Ordinary Shares is

£85,718,561.94 (approximately, JPY17,838,889,925), which was calculated under the assumption that the number of the Options set out in (2) above are exercised at the exercise prices respectively set out in (6) below.

 

(5)      Kind of shares, its details and numbers underlying the Option:

 

(i)                 Kind of shares

Ordinary Shares of the Company (the "Shares")

(ii)              Details of shares

With full voting rights and without any limitations or preference to the rights conferred to them

They will rank equally with all other shares then in issue, except for rights arising by reference to a record date prior to their allotment.

(iii)            Number of shares

20,506,833 Shares in total at the maximum

 

(6)      Amount to be paid upon exercise of the Option

 

For Sharesave, the Option will be exercised at £4.18 (approximately, JPY870)

 

Note:

Under the Sharesave, Eligible Sharesave Employees who apply will be granted an Option to acquire Shares at the end of a savings period at the relevant exercise price set out above. The exercise price and amount to be incorporated in capital is 80 per cent. of the average one day middle market quotation of a Company share on the London Stock Exchange on 13 August 2026.

 

Eligible Sharesave Employees means any person who:

 

(i)                 is an employee or a director of a "Constituent Company", (meaning Barclays and any subsidiary which participates in the Sharesave and which is bound by the provisions of the Sharesave) on the date on which eligibility to participate in the  Sharesave is determined; and

 

(ii)              has either (i) been in continuous employment with the Participating Company for a service period set by Barclays before the Sharesave is launched (which is currently on or before 1 June 2026) is a UK taxpayer; or (ii) been nominated by the Board for this purpose.

 

(7)      Condition to exercise the Option

 

Options will normally be exercisable for a period of six months (12 months in the case of death – see below) from the maturity date of the savings contract (the participant can choose to enter into a 3 or 5 year savings contract). Earlier exercise is permitted in the following circumstances:

 

(i)                 following cessation of employment by reason of death, disability, injury, redundancy, retirement or the business or company that the employee works for ceases to be part of the Company's group;

 

(ii)              when an employee reaches age 60 (for awards granted before 17 July 2013)

 

(iii)            where employment ceases more than three years from grant for any reason other than by reason of dismissal for misconduct;

 

(iv)             in the event of a takeover, amalgamation, reconstruction or winding-up of the Company, except in the case of an internal corporate reorganisation when the Board may decide to exchange existing Options for equivalent new options over shares in a new holding company.

 

Except where stated above, Options will lapse on cessation of employment.

 

(8)      Amount to be incorporate into capital out of the issue price of the shares when shares are issued upon exercise of the Option

 

£85,718,561.94 (approximately, JPY17,838,889,925) (estimated amount)

 

Note:

Calculated under the assumption that the number of the Options set out in (2) above are exercised at the exercise prices respectively set out in (6) above.

 

(9)      Matters concerning transfer of Option

 

Option shall be personal to the Option holder to whom it is granted and shall not be transferred, assigned or charged other than on death

 

(10)    Issue Method

 

Shall be done by way of allocating to Eligible Sharesave Employees.

 

(11)    Name of Underwriter

 

N/A

 

(12)    Areas in Which Issue will be Made

 

UK, Jersey, Guernsey and the Isle of Man.

 

(13)    Aggregate Amount of Proceeds from New Issuance, and Use of Such Proceeds and Amount and Timing of Each Use:

 

(i)         Aggregate Amount of Proceeds from New Issuance:

 

£85,718,561.94 (approximately, JPY17,838,889,925) (estimated amount)

 

Note:

The total amount of proceeds to be received from new issuance of Shares is an estimated amount as determined under the assumption that the number of Shares set out in (2) above in respect of Sharesave are offered at the Issue Price set out in (6) above.

 

 

(ii)       Use of Proceeds, and Amount and Timing of Each Use:

 

The proceeds to be received will be appropriated for the operating capital, etc., however, the contents, the amount by each use and the time to be used will be determined depending on the needs of Barclays at the relevant times; therefore, the use is currently undetermined.

 

(14)    Grant date of the Option

 

17 August 2026

 

Note:

This is the date when the formal invitation to join the Sharesave was made to all the Eligible Sharesave Employees in the UK, Jersey, Guernsey and the Isle of Man.  An Eligible Sharesave Employee may apply to be granted an Option under the Sharesave during a minimum 2 week period following invitation each year during his/her employment with the Constituent Company, and Shares will be issued at the end of the relevant savings periods under the Sharesave Plans on the exercise of an Option.

 

(15)    Name of the financial instruments exchange to which such securities is contemplated to be listed

 

Not applicable

 

Note:

The ordinary shares of the Company are admitted to trading on the London Stock Exchange. American Depositary Shares, each representing four ordinary shares of the Company, are listed on the New York Stock Exchange.

 

(16)    Total Shareholders' Equity of the Company

 

£3,350,480,398 (share capital, approximately, JPY697,268,475,628) (as of 18 September 2026)

 

(17)    Number of Issued Shares of the Company

 

13,401,921,592 Shares (as of 18 September 2026)